Fiduciary Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-38,595
| Closed | -$3.83M | – | 531 |
|
|
2019
Q3 | $3.83M | Buy |
38,595
+6,664
| +21% | +$633K | 0.1% | 143 |
|
|
2019
Q2 | $2.95M | Buy |
31,931
+3,133
| +11% | +$298K | 0.08% | 162 |
|
|
2019
Q1 | $2.72M | Buy |
28,798
+424
| +1% | +$37.1K | 0.07% | 170 |
|
|
2018
Q4 | $1.82M | Sell |
28,374
-1,526
| -5% | -$113K | 0.06% | 189 |
|
|
2018
Q3 | $2.68M | Buy |
29,900
+6,103
| +26% | +$539K | 0.08% | 170 |
|
|
2018
Q2 | $1.89M | Sell |
23,797
-2,639
| -10% | -$219K | 0.06% | 199 |
|
|
2018
Q1 | $2.36M | Buy |
26,436
+382
| +1% | +$36.7K | 0.07% | 176 |
|
|
2017
Q4 | $2.72M | Sell |
26,054
-2,947
| -10% | -$333K | 0.08% | 165 |
|
|
2017
Q3 | $4.23M | Sell |
29,001
-138
| -0.5% | -$18.8K | 0.13% | 131 |
|
|
2017
Q2 | $3.78M | Buy |
29,139
+1,834
| +7% | +$225K | 0.12% | 133 |
|
|
2017
Q1 | $3.4M | Sell |
27,305
-1,635
| -6% | -$196K | 0.1% | 142 |
|
|
2016
Q4 | $3.35M | Buy |
28,940
+3,877
| +15% | +$432K | 0.11% | 148 |
|
|
2016
Q3 | $2.62M | Sell |
25,063
-17
| -0.1% | -$1.84K | 0.09% | 168 |
|
|
2016
Q2 | $2.47M | Buy |
25,080
+1,082
| +5% | +$112K | 0.09% | 168 |
|
|
2016
Q1 | $2.4M | Sell |
23,998
-23
| -0.1% | -$2.37K | 0.08% | 172 |
|
|
2015
Q4 | $2.88M | Buy |
24,021
+143
| +0.6% | +$16.5K | 0.12% | 141 |
|
|
2015
Q3 | $2.58M | Sell |
23,878
-71
| -0.3% | -$8.81K | 0.12% | 143 |
|
|
2015
Q2 | $2.77M | Buy |
23,949
+87
| +0.4% | +$9.95K | 0.12% | 144 |
|
|
2015
Q1 | $2.75M | Buy |
23,862
+272
| +1% | +$32.5K | 0.11% | 143 |
|
|
2014
Q4 | $2.64M | Buy |
23,590
+1,804
| +8% | +$190K | 0.11% | 141 |
|
|
2014
Q3 | $2.06M | Buy |
21,786
+556
| +3% | +$50.2K | 0.09% | 147 |
|
|
2014
Q2 | $1.82M | Buy |
21,230
+10,390
| +96% | +$790K | 0.08% | 158 |
|
|
2014
Q1 | $757K | Buy |
10,840
+1,000
| +10% | +$79.2K | 0.03% | 204 |
|
|
2013
Q4 | $832K | Sell |
9,840
-1,400
| -12% | -$111K | 0.04% | 190 |
|
|
2013
Q3 | $867K | Buy |
11,240
+400
| +4% | +$28K | 0.04% | 179 |
|
|
2013
Q2 | $634K | Buy |
+10,840
| New | +$652K | 0.03% | 198 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Fiduciary Trust's CELG Position: Q4 2019 in Review
Fiduciary Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 38,595 shares — an estimated $3.83M sold.
Fiduciary Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.23M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Fiduciary Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Fiduciary Trust sold 38,595 Celgene Corp shares in Q4 2019, an estimated $3.83M.
- Fiduciary Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Fiduciary Trust's Celgene Corp position peaked at $4.23M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Fiduciary Trust's 13F filing for Q4 2019, filed 4 Feb 2020.